Advanced Ovarian Cancer

Oncology·MeSH: Ovarian Neoplasms

Prevalence

24.0 / 100K

Incidence

10.6 / 100K/yr

0 drugs in development·0 companies·2 clinical trials

Frequently asked questions

How many clinical trials target Advanced Ovarian Cancer?

There are 2 clinical trials targeting Advanced Ovarian Cancer tracked by BioSniper.

What is the prevalence of Advanced Ovarian Cancer?

The estimated prevalence of Advanced Ovarian Cancer is approximately 24.0 per 100,000 population.

Deep-dive into Advanced Ovarian Cancer

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Advanced Ovarian Cancer — Drugs in Development & Clinical Trials | BioSniper